Acumen Pharmaceuticals Inc. (ABOS) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Acumen Pharmaceuticals In...

    NASDAQ: ABOS · Real-Time Price · USD
    1.73
    -0.04 (-2.26%)
    At close: Oct 03, 2025, 3:59 PM
    1.77
    2.31%
    After-hours: Oct 03, 2025, 06:27 PM EDT

    Acumen Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -102.33M -52.37M -42.86M -100.61M
    Depreciation & Amortization
    		 178K 184K 169K 4K
    Stock-Based Compensation
    		 9.63M 6.14M 3.06M 922K
    Other Working Capital
    		 7.38M 4.13M 3.43M -259K
    Other Non-Cash Items
    		 -5.35M -888K 487K 81.42M
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 11.65M 3.87M 3.99M 298K
    Operating Cash Flow
    		 -86.22M -43.06M -35.15M -17.96M
    Capital Expenditures
    		 -16K -21K -161K -40K
    Cash Acquisitions
    		 n/a 3K -39.35K n/a
    Purchase of Investments
    		 -170.73M -250.63M -41.51M -104.08M
    Sales Maturities Of Investments
    		 218.77M 78.98M 80.86M n/a
    Other Investing Acitivies
    		 n/a n/a 39.35K n/a
    Investing Cash Flow
    		 48.03M -171.67M 39.19M -104.12M
    Debt Repayment
    		 -739K 30M n/a n/a
    Common Stock Repurchased
    		 -41K n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -230K -151K 115K 1.88M
    Financial Cash Flow
    		 6.93M 151.75M 3.91M 200.47M
    Net Cash Flow
    		 -31.26M -62.98M 7.94M 78.39M
    Free Cash Flow
    		 -86.23M -43.09M -35.31M -18M

    Add to Watchlist